AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Evaluation of RSB11-HI Postbiotic Supplementation for Supporting Weight Management, Metabolic Wellness, and Quality of Life in Healthy Adults

RecruitingNAAges 18 Years - 55 YearsAllAble Biolabs, LLC
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This randomized, double-blind, placebo-controlled clinical trial will evaluate the safety, tolerability, and efficacy of RSB11-HI, a heat-inactivated postbiotic, in healthy adults over an 8-week intervention period. Participants will be classified into one of three predefined study populations-General Healthy, Perimenopausal, or Mild Inflammation-and will then be randomized within their assigned population to receive either RSB11-HI or placebo. The study will evaluate the effects of supplementation on healthy weight management, metabolic wellness, gastrointestinal health, and quality of life, while also exploring whether responses differ among the predefined study populations.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Male or female, 18 to 55 years of age. * Body Mass Index (BMI) between 23 and 32 kg/mยฒ at screening. * Able and willing to provide electronic informed consent. * Willing and able to comply with all study procedures and scheduled assessments. * Willing to maintain usual dietary habits and physical activity throughout the study period. * Access to a smartphone, tablet, or computer with reliable internet connectivity to complete remote study assessments. * Willing to refrain from initiating new dietary supplements, structured weight management programs, or significant lifestyle modifications intended to influence study outcomes during study participation. Exclusion Criteria: * Participation in another interventional clinical study within 30 days prior to screening. * Current use of prescription medications intended for weight management. * Current use of probiotic or postbiotic supplements that cannot be discontinued at least 4 weeks prior to enrollment. * Antibiotic use within 4 weeks prior to screening. * Pregnancy, planned pregnancy during the study period, or breastfeeding. * Known allergy or hypersensitivity to any component of the investigational product or placebo. * History of any gastrointestinal condition, metabolic disorder, or other clinically significant medical condition that, in the opinion of the investigator, could interfere with study participation or interpretation of study results. * Any physical, psychological, or behavioral condition that, in the opinion of the investigator, would make participation unsafe or compromise compliance with the study protocol.
๐Ÿ’Š

What it tests

  • RSB11-HI Heat-Inactivated Postbiotic
  • Placebo
๐Ÿ“

Where

1 site
Able Biolabs LLC
Dallas, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy